REQUEST A DEMO
Total
USD $0.00
Search more companies

Compania de Investigaciones Clinicas en Reumatologia Reumavit S.A. (Ecuador)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Compania de Investigaciones Clinicas en Reumatologia Reumavit S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Spanish Download a sample report

Compania de Investigaciones Clinicas en Reumatologia Reumavit S.A. is a company in Ecuador, with a head office in Quito. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. Compania de Investigaciones Clinicas en Reumatologia Reumavit S.A. was incorporated on May 06, 2016. The total number of employees is currently 4 (2019). From the latest financial highlights, Compania de Investigaciones Clinicas en Reumatologia Reumavit S.A. reported a net sales revenue increase of 553.85% in 2020. Its’ total assets recorded a growth of 28.95%. The net profit margin of Compania de Investigaciones Clinicas en Reumatologia Reumavit S.A. increased by 23.56% in 2020.

Headquarters
Veintimilla E2-41, Betancourt Robert Bldg.
Quito; Pichincha;

Contact Details: Purchase the Compania de Investigaciones Clinicas en Reumatologia Reumavit S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Compania de Investigaciones Clinicas en Reumatologia Reumavit S.A. report to view the information.
Outstanding Shares:
Purchase the Compania de Investigaciones Clinicas en Reumatologia Reumavit S.A. report to view the information.
Registered Capital:
Purchase the Compania de Investigaciones Clinicas en Reumatologia Reumavit S.A. report to view the information.
Incorporation Date:
May 06, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
51.25%
Purchase this report to view the information.
47.5%
Purchase this report to view the information.
1.25%
Company Performance
Financial values in the chart are available after Compania de Investigaciones Clinicas en Reumatologia Reumavit S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
553.85%
Total operating revenue
164.22%
Operating profit (EBIT)
1795.67%
EBITDA
252.59%
Net Profit (Loss) for the Period
1709%
Total assets
28.95%
Total equity
32.67%
Operating Profit Margin (ROS)
43.83%
Net Profit Margin
23.56%
Return on Equity (ROE)
16.63%
Quick Ratio
0.69%
Cash Ratio
0.69%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?